Amy Schmotzer

A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors.

Andrew J. Lepisto, A. James Moser, Herbert J. Zeh et al. · PubMed · 2008 · 190 citations

Muc1 Peptide, Phase I/ii Study, Immunology +16

Frailty as Tested by Gait Speed is an Independent Risk Factor for Cirrhosis Complications that Require Hospitalization

Michael A. Dunn, Deborah A. Josbeno, Amit D. Tevar et al. · The American Journal of Gastroenterology · 2016 · 137 citations

The gap between clinically assessed physical performance and objective physical activity in liver transplant candidates

Michael A. Dunn, Deborah A. Josbeno, Amy Schmotzer et al. · Liver Transplantation · 2016 · 96 citations

Physical Activity, Physiological Status, Solid Organ Transplantation +22

Phase II Study of Docetaxel and Gefitinib as Second-Line Therapy in Gemcitabine Pretreated Patients with Advanced Pancreatic Cancer

Joanna M. Brell, Khalid Matin, Terry Evans et al. · Oncology · 2009 · 34 citations

Gait Speed and Grip Strength Are Associated With Dropping Out of the Liver Transplant Waiting List

Shreyus S. Kulkarni, H. Chen, Deborah A. Josbeno et al. · Transplantation Proceedings · 2019 · 24 citations

Transplantation Surgery, Transplantation, Hepatology +12